News
-
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma appoints Dr. Dongzhou Jeffery Liu as Chairman and CEO, replacing Prof. Andreas Pahl. The biotech company focuses on ADC technology for cancer treatment -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
Heidelberg Pharma AG announces changes to the Executive Management Board - Dr. Dongzhou Jeffery Liu appointed as Chairman of the Executive Board and Chief Executive Officer -
-
-
COMMUNIQUÉ DE PRESSE
Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma
Heidelberg Pharma's lead ATAC candidate HDP-101 shows promising progress in Phase I/IIa trial for multiple myeloma, including stringent complete remissions. R&D webinar scheduled on 11 Nov 2025 -
